Farum
Denmark
85
2021-08-26
The entities that hold a legal rights for patent applications filed by inventor Lau Jesper:
Jesper Lau from Farum, DK has applied for patents for these inventions. The list has both pending applications and granted patents:
Compounds for treatment of obesity
#2 | 2020-04-23Double-acylated GLP-1 derivatives
#3 | 2018-08-30Double-acylated GLP-1 derivatives
#4 | 2017-05-25GLP-1 derivatives
#5 | 2017-04-27Double-acylated GLP-1 compounds
#6 | 2016-04-21Novel GLP-1 Derivatives
#7 | 2015-12-03NOVEL GLP-1 RECEPTOR AGONISTS WITH CHOLESTEROL EFFLUX ACTIVITY
#8 | 2015-07-30Double-Acylated GLP-1 Derivatives with a Linker
#9 | 2015-05-14Double-acylated GLP-1 derivatives
#10 | 2015-01-22Glucagon-like peptide-1 derivatives and their pharmaceutical use
#11 | 2014-10-09GLP-1 derivatives
#12 | 2014-10-02Truncated GLP-1 derivatives and their therapeutical use
#13 | 2014-06-26Double-acylated GLP-1 derivatives
#14 | 2014-01-09Peptides derivatized with A-B-C-D- and their therapeutical use
#15 | 2013-12-19Double-acylated GLP-1 derivatives with a linker
#16 | 2013-10-31Double-acylated GLP-1 derivatives
#17 | 2013-09-19Novel GLP-1 Derivatives
#18 | 2013-09-19TREATING DIABETES USING INHIBITORS OF IL-1
#19 | 2013-03-07Biaryl phosphodiesterase inhibitors
#20 | 2013-02-28NOVEL GLP-1 DERIVATIVES
#21 | 2013-02-28GLP-1 analogues and derivatives
#22 | 2013-02-14ALBUMIN-BINDING CONJUGATES COMPRISING FATTY-ACID AND PEG
#23 | 2012-11-22Acylated GLP-1 compounds
#24 | 2012-11-15GLP-1 compounds
#25 | 2012-11-08Acylated exendin-4 compounds
#26 | 2012-06-28Urea glucokinase activators
#27 | 2011-12-08ARYL CARBONYL DERIVATIVES AS THERAPEUTIC AGENTS
#28 | 2011-12-08Protracted exendin-4 compounds
#29 | 2011-09-22BENZAMIDE GLUCOKINASE ACTIVATORS
#30 | 2011-07-07Double-acylated GLP-1 derivatives
#31 | 2011-05-05Amylin derivatives
#32 | 2011-04-07N-heteroaryl indole carboxamides and analogues thereof, for use as glucokinase activators in the treatment of diabetes
#33 | 2011-04-07Glucagon-Like Peptide-1 derivatives and their pharmaceutical use
#34 | 2011-03-31Urea glucokinase activators
#35 | 2011-03-10Heteroaryl-ureas and their use as glucokinase activators
#36 | 2010-12-30Benzamide glucokinase activators
#37 | 2010-12-16Semi-recombinant preparation of GLP-1 analogues
#38 | 2010-12-02Novel GLP-1 Derivatives
#39 | 2010-11-18TRUNCATED GLP-1 DERIVATIES AND THEIR THERAPEUTICAL USE
#40 | 2010-10-14PEPTIDES DERIVATIZED WITH A-B-C-D- AND THEIR THERAPEUTICAL USE
#41 | 2010-09-02IMPROVED DERIVATIVES OF AMYLIN
#42 | 2010-08-12Heteroaryl-ureas and their use as glucokinase activators
#43 | 2010-07-08Peptides for Treatment of Obesity
#44 | 2010-02-18Urea glucokinase activators
#45 | 2010-01-21Peptides for Use in the Treatment of Obesity
#46 | 2010-01-21TREATING DIABETES USING INHIBITORS OF IL-1
#47 | 2010-01-14Urea glucokinase activators
#48 | 2009-12-24Acylated Exendin-4 Compounds
#49 | 2009-09-24Synthesis and Application of New Structural Well Defined Branched Polymers as Conjugating Agents for Peptides
#50 | 2009-08-27Heteroaryl-ureas and their use as glucokinase activators
#51 | 2009-07-09Benzamide glucokinase activators
#52 | 2009-06-18Acylated GLP-1 compounds
#53 | 2009-06-11Use of Ghrelin Antagonists to the Treatment of Certain CNS Diseases
#54 | 2009-06-04Glucagon Antagonists/Inverse Agonists
#55 | 2009-05-07Dicycloalkyl urea glucokinase activators
#56 | 2009-04-23Ureido-thiazole glucokinase activators
#57 | 2009-04-16Amylin derivatives
#58 | 2009-03-05Dimeric Peptide Agonists of the Glp-1 Receptor
#59 | 2009-02-26Mixtures of Amylin and Insulin
#60 | 2009-02-05Insulin Derivatives Conjugated with Structurally Well Defined Branched Polymers
#61 | 2009-01-01NOVEL GLP-1 ANALOGUES LINKED TO ALBUMIN-LIKE AGENTS
#62 | 2008-12-25Dicycloalkylcarbamoyl ureas as glucokinase activators
#63 | 2008-11-06Condensed Thiophene Derivatives and Their Use as Cyclic Glp-1 Agonists
#64 | 2008-10-09Protracted exendin-4 compounds
#65 | 2008-08-28Extended GLP-1 compounds
#66 | 2008-07-31Protracted GLP-1 compounds
#67 | 2008-06-10Aryl carbonyl derivatives as therapeutic agents
#68 | 2008-05-22Aryl carbonyl derivatives as therapeutic agents
#69 | 2008-05-22Aryl carbonyl derivatives as therapeutic agents
#70 | 2007-08-30Novel Glp-1 Derivatives
#71 | 2007-04-26Novel GLP-1 analogues linked to albumin-like agents
#72 | 2007-03-08Heteroaryl-ureas and their use as glucokinase activators
#73 | 2007-02-22Novel GLP-1 compounds
#74 | 2007-01-18Novel Glucagon Antagonists/Inverse Agonists
#75 | 2006-10-03Method of inhibiting protein tyrosine phosphatase 1B and/or T-cell protein tyrosine phosphatase 4 and/or other PTPases with an Asp residue at position 48
#76 | 2006-08-17Aryl carbonyl derivatives as therapeutic agents
#77 | 2006-08-17Synthesis and application of new structural well defined branched polymers as conjugating agents for peptides
#78 | 2006-03-28Modulators of Protein Tyrosine Phosphatases (PTPases)
#79 | 2005-11-17Novel glucagon antagonists/inverse agonists
#80 | 2005-10-11Glucagon antagonists/inverse agonists
#81 | 2005-09-15Glucagon antagonists/inverse agonists
#82 | 2005-09-06Compounds with growth hormone releasing properties
#83 | 2005-08-09Non-peptide GLP-1 agonists
#84 | 2005-04-19Glucagon antagonists/inverse agonists
#85 | 2005-04-05Glucagon antagonists/inverse agonists
91491 ⎘